Journal Title：Assay And Drug Development Technologies

ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.

ASSAY and Drug Development Technologies coverage includes:

-Assay design, target development, and high-throughput technologies-

Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-

Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-

Approaches to assays configured for gene families, inherited, and infectious diseases-

Assays and strategies for adapting model organisms to drug discovery-

The use of stem cells as models of disease-

Translation of phenotypic outputs to target identification-

Exploration and mechanistic studies of the technical basis for assay and screening artifacts

《分析和藥物開發技術》提供了新技術和強大工具，可實現早期篩選的關鍵進展。本期刊上發表的這項研究為藥物發現和開發提供了重要的治療方法和平臺。這本享有盛譽的同行評審期刊刊登原創論文、應用型技術評論、新興研究領域的專題以及方法和技術應用報告。

分析和藥物開發技術報道包括：

-分析設計、靶標開發和高通量技術-

通過臨床前候選藥物選擇實現先導化合物優化和藥物化學-

實驗室自動化、樣品管理、生物信息學、數據挖掘、虛擬篩選和數據分析-

針對基因家族、遺傳和傳染病配置的分析方法-

使模型生物適應藥物發現的分析和策略-

使用干細胞作為疾病模型-

將表型輸出轉化為靶標識別-

分析和篩選制品的技術基礎探索和機制研究

Assay And Drug Development Technologies創刊于2002年，由Mary Ann Liebert Inc.出版商出版，收稿方向涵蓋生化研究方法 - 醫學全領域，此期刊水平偏中等偏靠后，在所屬細分領域中專業影響力一般，過審相對較易，如果您文章質量佳，選擇此期刊，發表機率較高。平均審稿速度 12周，或約稿 ，影響因子指數1.6，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。